Adeno-associated virus (AAV) is a member of the parvovirus family, and its genome is a single-stranded DNA consisting of 4682 nucleotides. AAV is a dependent virus that requires other viruses such as adenovirus or herpes simplex virus, or auxiliary factors to provide auxiliary functions in order to replicate. In the absence of auxiliary viruses, after AAV infects cells, its genome will be integrated into the cell chromosome and become latent, without producing progeny viruses. AAV includes 12 different AAV serotypes. The corresponding cell surface receptors during the infection process of different serotypes are not the same, so different tissues and organs in the animal body show different affinities and infection efficiencies. Among them, AAV5 shows a certain affinity for the lungs, eyes, and nervous system.
Cre recombinase is an enzyme that promotes recombination between specific DNA sequences (called loxP sites). When AAV5 is designed to carry the Cre recombinase gene, it can be used to activate or deactivate genes at loxP sites in a targeted manner, making it a powerful tool for researchers studying gene function and regulation.
Genetic changes caused by thalamic hemorrhage may contribute to the development of thalamic pain. RNA N6-methyladenosine (m6A) modification is an additional layer of gene regulation. Whether fat mass and obesity-associated protein (FTO), an m6A demethylase, is involved in hemorrhage-induced thalamic pain is unknown. In this study, FTO was detected in neuronal nuclei of the thalamus. FTO protein levels, but not mRNA, increased over time in the ipsilateral thalamus 1-14 days after microinjection of type IV collagenase (Coll IV). Intraperitoneal injection of MA or AAV5-Cre microinjection into the thalamus of Ftofl/fl mice attenuated Coll IV microinjection-induced ipsilateral thalamic TLR4 upregulation and tissue damage as well as the generation and maintenance of contralateral nociceptive hypersensitivity. Thalamic microinjection of AAV5-Fto increased TLR4 expression and induced hypersensitivity to mechanical, heat, and cold stimuli. Mechanistically, Coll IV microinjection produced an increase in FTO binding to Tlr4 mRNA, an FTO-dependent loss of m6A sites in Tlr4 mRNA and a reduction in the binding of YTHDF2 to Tlr4 mRNA in the ipsilateral thalamus. These findings suggest that FTO is involved in hemorrhage-induced thalamic pain by stabilizing TLR4 upregulation in thalamic neurons.
The researchers knocked down thalamic FTO in male Ftofl/fl mice by microinjecting AAV5-Cre into the unilateral thalamic VPL and VPM 5 weeks before Coll IV or by microinjecting saline into the same area. AAV5-Gfp was used as a negative control. In the entire ipsilateral thalamus of male Ftofl/fl mice microinjected with AAV5-Cre at Coll IV, the increase in FTO protein levels caused by Coll IV microinjection was significantly blocked 7 days after microinjection of AAV5-Cre (Figure 1A). Unexpectedly, male Ftofl/fl mice microinjected with AAV5-Cre failed to change the basal level of FTO protein in the ipsilateral thalamus 7 days after microinjection of saline (Figure 1A). Consistent with the above behavioral observations, significant mechanical allodynia, heat hyperalgesia, and cold hyperalgesia were observed on days 1, 3, and 7 after Coll IV microinjection in AAV5-Gfp pre-microinjected male Ftofl/fl mice contralaterally (but not ipsilaterally) (Figure 1B-F). However, these hyperalgesias were significantly reduced in Coll IV male Ftofl/fl mice pre-microinjected with AAV5-Cre (Figure 1B-D). Similar behavioral responses were observed in female Ftofl/fl mice.
Figure 1. Effect of thalamic pre-microinjection of AAV5-Cre on Coll IV microinjection-induced FTO protein expression and thalamic pain genesis in male Ftofl/fl mice. (Fu G, et al., 2021)
Customer Reviews
Perfect tool
The Cre recombinase activity was robust, providing precise genetic modifications. It’s the perfect tool for anyone looking to streamline their gene-editing processes!
Write a Review